Table 4.
In-vitro xanthine oxidase inhibitory activity of the selected compounds
| COMPOUNDS |
Percentage Inhibition (Mean±SEM)
|
IC
50
μg/mL (Mean±SEM) |
||||
|---|---|---|---|---|---|---|
|
Concentration (μg/mL)
| ||||||
| 5 | 20 | 40 | 60 | 80 | ||
| Epigallocatechin | 31.23±0.73 | 44.53±0.93 | 54.32±0.64 | 74.53±1.21 | 87.54±0.87 | 36±0.64 |
| Acacatechin | 32.00±0.75 | 39.33±0.92 | 52.33±0.64 | 76.00±0.78 | 85.33±1.26 | 27±1.16 |
| Myricetin | 28.43±0.42 | 46.76±0.65 | 58.45±0.54 | 72.82±0.76 | 86.72±0.84 | 26±0.72 |
| Naringenin | 33.26±0.65 | 48.46±0.82 | 64.73±0.48 | 82.65±0.65 | 92.76±0.45 | 22±0.64 |
| Daidzein | 32.87±0.54 | 46.57±0.62 | 62.37±0.65 | 78.65±0.83 | 87.54±0.76 | 23±0.75 |
| Glycitein | 29.64±0.76 | 68.76±0.93 | 75.46±0.98 | 87.68±0.54 | 95.63±0.72 | 12±0.86 |
| Allopurinol | 33.33±0.70 | 38.00±0.86 | 66.00±1.20 | 76.67±1.42 | 97.33±0.92 | 29±0.28 |